ACM
ELV icon

Aljian Capital Management’s Elevance Health ELV Stock Holding History

Aljian Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Sell
2,066
-71
-3% -$23.3K 0.12% 79
2025
Q4 		$749K Sell
2,137
-142
-6% -$48K 0.15% 67
2025
Q3 		$736K Sell
2,279
-46
-2% -$14.3K 0.15% 73
2025
Q2 		$904K Sell
2,325
-97
-4% -$39K 0.2% 61
2025
Q1 		$1.05M Buy
2,422
+7
+0.3% +$2.81K 0.25% 52
2024
Q4 		$891K Buy
2,415
+8
+0.3% +$3.35K 0.19% 55
2024
Q3 		$1.25M Buy
+2,407
New +$1.29M 0.29% 42

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Aljian Capital Management's ELV Position: Q1 2026 in Review

Aljian Capital Management reduced its Elevance Health (ELV) stake by 3.3% in Q1 2026, selling an estimated $23.3K and leaving 2,066 shares worth $605K. The position accounts for 0.12% of the portfolio, ranked #79.

Aljian Capital Management first reported a position in ELV in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.25M in Q3 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Aljian Capital Management held 2,066 shares of Elevance Health worth $605K as of Q1 2026.
  • Aljian Capital Management sold 71 Elevance Health shares in Q1 2026, an estimated $23.3K.
  • Elevance Health made up 0.12% of Aljian Capital Management's portfolio in Q1 2026, its #79 holding.
  • Aljian Capital Management first reported a position in Elevance Health in Q3 2024 and has held it in 7 quarters since.
  • Aljian Capital Management's Elevance Health position peaked at $1.25M in Q3 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Aljian Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.